- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07293156
Impact of Pilates Exercises Added to Pelvic Floor Muscle Training and Sildenafil on Diabetic Erectile Dysfunction. (PilatesDED2025)
Pilates Exercises Added to Pelvic Floor Muscle Training and Sildenafil for Diabetic Erectile Dysfunction: A Randomized Controlled Trial
Erectile dysfunction (ED) has a prevalence of 52.5% in diabetic male patients, as described in a meta-analysis of 145 studies, including 88,577 men with type 1 and type 2 diabetes.
In men, ED can cause sexual dissatisfaction and distress, unsatisfactory relationships, and marital tension
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Pilates emerged as a method of rehabilitation during World War I, when Joseph Hubertus Pilates applied his knowledge to rehabilitate injured men. The popularity of the method grew most in the 1980. More recently, Pilates has been used resulting in improved fitness (flexibility, strength and balance) and body consciousness. The method features ground-based exercises created by Joseph Pilates.
Because most Pilates exercises are performed in conjunction with the recruitment of PF muscle fibres, many Pilates instructors believe that the method can produce a significant increase in the force or contractility of the muscles. Furthermore, if Pilates promotes an improvement in the functioning of the pelvic floor muscles (PFM), it may be an alternative for the treatment and prevention of pelvic floor dysfunction.
Up till now, no published trials about impact of Pilate exercises on diabetic erectile dysfunction.
A total of 60 patients (n=30 per group), diagnosed with diabetic erectile dysfunction in the past 6 months. Participants will be recruited from Benha University hospital and local andrology and urology clinics in benha and giza . Participants will be screened for eligibility prior to being enrolled in the study participating in the study assessments.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Benha
-
Banhā, Benha, Egypte
- Outpatient clinic, faculty of Physical Therapy, Benha university
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Men aged 40-60 years.
- Married.
- Diagnosed with type 2 diabetes mellitus for >5 years, with initial diagnosis confirmed by HbA1c >6.5%.
- Arteriogenic erectile dysfunction (ED) of >6 months' duration, diagnosed using the International Index of Erectile Function-5 (IIEF-5),confirmed by penile Doppler ultrasonography showing peak systolic velocity (PSV) of the cavernosal arteries <25 cm/s.
- Body mass index (BMI) <30 kg/m².
Exclusion Criteria:
- Poorly controlled diabetes mellitus (HbA1c >9%).
- Neurogenic, venogenic, or psychogenic ED.
- Cardiac conditions contraindicating sexual activity.
- Neurological disorders or spinal cord injury.
- Alcohol abuse or illicit drug use.
- Chronic hematological disorders.
- Active genitourinary infection.
- Severe hypogonadism.
- History of radical prostatectomy, pelvic surgery, or pelvic trauma.
- Penile prosthesis implantation.
- Current or previous participation in a structured pelvic floor muscle training or sexual rehabilitation program.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Expérimental
|
The program had 11 mat exercises: Pilates breathing, spine stretch, swan, shoulder bridge, hundreds, double leg stretch, footwork, roll up, single leg stretch, leg pull back, and kick front and back, It had three phases of four weeks each. In the beginner phase (weeks 1 to 4), participants did one set of six to eight repetitions of each exercise, using supported positions and modified movements to establish breathing coordination and lumbopelvic control. In the intermediate phase (weeks 5 to 8), they did two sets of eight to 10 repetitions with larger movement amplitude, longer lever arms, and more challenging limb movements. In the advanced phase (weeks 9 to 12), they did two sets of 10 to 12 repetitions of more complex variations with greater stabilization demands, provided they kept adequate movement control. Participants attended an educational session conducted by a physiotherapist covering pelvic floor anatomy, the physiology of erection, and the roles of the ischiocavernosus and bulbocavernosus muscles in erectile function. They were instructed on proper pelvic floor muscle contraction using simulated interruption of urine flow and maximal voluntary contractions. A home-based PFMT program was prescribed, initially performed in the supine position with knees flexed and subsequently progressed to sitting or standing positions as tolerated. Participants were instructed to perform PFMT twice daily (morning and evening), consisting of 15 short contractions (1 second each) and 15 sustained contractions (6-10 seconds each). Adherence was monitored through a mobile messaging application, via which participants reported completion of their daily exercises and received reminders when necessary. Participants received sildenafil citrate 25 mg orally once daily and sildenafil citrate 50 mg orally on demand, taken approximately 1 hour before sexual intercourse, throughout the study period. |
|
Comparateur actif: Comparateur actif
|
Participants attended an educational session conducted by a physiotherapist covering pelvic floor anatomy, the physiology of erection, and the roles of the ischiocavernosus and bulbocavernosus muscles in erectile function. They were instructed on proper pelvic floor muscle contraction using simulated interruption of urine flow and maximal voluntary contractions. A home-based PFMT program was prescribed, initially performed in the supine position with knees flexed and subsequently progressed to sitting or standing positions as tolerated. Participants were instructed to perform PFMT twice daily (morning and evening), consisting of 15 short contractions (1 second each) and 15 sustained contractions (6-10 seconds each). Adherence was monitored through a mobile messaging application, via which participants reported completion of their daily exercises and received reminders when necessary. Participants received sildenafil citrate 25 mg orally once daily and sildenafil citrate 50 mg orally on demand, taken approximately 1 hour before sexual intercourse, throughout the study period. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
International Index of Erectile Function-5 (IIEF-5) scale.
Délai: Baseline and after 12 weeks
|
The IIEF-5 scale is used to assess patients with erectile dysfunction to determine the extent of the erectile function in patients. The full-scale 15-item version has five domains: erectile function, orgasmic function, sexual desire, intercourse satisfaction and overall sexual satisfaction. The shortened 5-item version is on a scale of 5 to 25: 22-25: No erectile dysfunction 17-21: Mild erectile dysfunction 12-16: Mild to moderate erectile dysfunction 8-11: Moderate erectile dysfunction 5-7: Severe erectile dysfunction |
Baseline and after 12 weeks
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
penile perfusion
Délai: Base line and after 12 weeks
|
Colour-coded duplex sonography (5-10 MHz probes) will be used for the evaluation of penile perfusion. Half ml of a vasoactive agent (trimix solution) will be injected into the corpus cavernosum. The systolic and diastolic velocities (cm/s) will be performed at 10 and 30 min for both cavernous artery. Re-dosing with 0.5 ml of trimax solution will be performed for patients who did not achieve adequate hardness. The highest values obtained will be recorded. The Doppler indices of the right and left cavernous arteries: peak systolic velocity (PSV) |
Base line and after 12 weeks
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
- Maladies urogénitales
- Maladies génitales
- Maladies du système endocrinien
- Les troubles mentaux
- Maladies génitales, sexe masculin
- Maladies urogénitales masculines
- Maladies métaboliques
- Troubles du métabolisme du glucose
- Dysfonction sexuelle, physiologique
- Dysfonctions sexuelles, psychologiques
- Maladies nutritionnelles et métaboliques
- Diabète sucré
- Dysérection
- Thérapeutique
- Modalités de physiothérapie
- Techniques de mouvement d'exercice
Autres numéros d'identification d'étude
- Pilate Exercises for DED2025
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .